Buscar resultados de ensayos clínicos
Neutropenia - 63 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. Condición: Chemotherapy-induced Febrile Neutropenia Fecha: 2013-01-08 |
Completed |
Nombre del estudio: Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy Condición: Chemotherapy-induced Febrile Neutropenia Fecha: 2014-06-10 |
Completed |
Nombre del estudio: Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia Condición: Non-Interventional Study Fecha: 2016-11-03 Intervenciones: Other: Overall satisfaction questionnaires of home use of Nivestim |
Recruiting |
Nombre del estudio: A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study) Condición: Early Stage Breast Cancer Fecha: 2015-04-15 |
Completed |
Nombre del estudio: Efficacy and Safety Study With MYL-1401H and Neulasta Condición:
Fecha: 2015-06-08 Intervenciones: |
Completed |
Nombre del estudio: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents Condición:
|
Completed |
Nombre del estudio: Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy Condición:
|
Recruiting |
Nombre del estudio: A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia Condición: Early Stage Breast Cancer Fecha: 2016-06-24 Intervenciones: Drug: Neupogen Subcutaneous injections Other Name: F |
Completed |
Nombre del estudio: Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor Condición:
|